Post-transcriptional control of the interferon system

Biochimie

Volumn 89, Issue 6-7, 2007, Pages 761-769

  Khabar, Khalid S A ^a   Young, Howard A ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

3 Untranslated regions; AU rich elements; Interferons; mRNA stability; Post transcriptional

Indexed keywords

ADENINE; ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERFERON; MESSENGER RNA; PROTEIN KINASE R; RIBONUCLEASE L; URACIL;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; IMMUNE RESPONSE; NEGATIVE FEEDBACK; NONHUMAN; PROTEIN INDUCTION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; RNA EDITING; RNA SEQUENCE; RNA STABILITY; RNA TRANSLATION; TRANSCRIPTION REGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; EIF-2 KINASE; ENDORIBONUCLEASES; FEEDBACK, BIOCHEMICAL; HUMANS; INTERFERON TYPE II; INTERFERON-BETA; INTERFERONS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; RNA PROCESSING, POST-TRANSCRIPTIONAL; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 34347214770     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2007.02.008     Document Type: Review

References (86)

1. Sehgal P.B., Tamm I., and Vilcek J. Human interferon production: superinduction by 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole. Science 190 (1975) 282-284
2. Cavalieri R.L., Havell E.A., Vilcek J., and Pestka S. Induction and decay of human fibroblast interferon mRNA. Proc. Natl Acad. Sci. U.S.A. 74 (1977) 4415-4419
3. Khabar K.S., Dhalla M., Siddiqui Y., Zhou A., Al-Ahdal M.N., Der S.D., Silverman R.H., and Williams B.R. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. J. Interferon Cytokine Res. 20 (2000) 653-659
4. Zhou A., Paranjape J., Brown T.L., Nie H., Naik S., Dong B., Chang A., Trapp B., Fairchild R., Colmenares C., and Silverman R.H. Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L. EMBO J. 16 (1997) 6355-6363
5. Zhou A., Paranjape J.M., Der S.D., Williams B.R., and Silverman R.H. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258 (1999) 435-440
6. Samuel M.A., Whitby K., Keller B.C., Marri A., Barchet W., Williams B.R., Silverman R.H., Gale Jr. M., and Diamond M.S. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 80 (2006) 7009-7019
7. Sehgal P.B., and Tamm I. Two mechanisms contribute to the superinduction of poly(I).poly(C)-induced human fibroblast interferon production. Virology 92 (1979) 240-244
8. Lebendiker M.A., Tal C., Sayar D., Pilo S., Eilon A., Banai Y., and Kaempfer R. Superinduction of the human gene encoding immune interferon. EMBO J. 6 (1987) 585-589
9. Tan Y.H., and Berthold W. A mechanism for the induction and regulation of human fibroblastoid interferon genetic expression. J. Gen. Virol. 34 (1977) 401-411
10. Whittemore L.A., and Maniatis T. Postinduction repression of the beta-interferon gene is mediated through two positive regulatory domains. Proc. Natl Acad. Sci. U.S.A. 87 (1990) 7799-7803
11. Kruys V., Wathelet M., Poupart P., Contreras R., Fiers W., Content J., and Huez G. The 3′ UTR region of the human interferon-beta mRNA has an inhibitory effect on translation. Proc. Natl Acad. Sci. U.S.A. 84 (1987) 6030-6034
12. van Heuvel M., Bosveld I.J., Luyten W., Trapman J., and Zwarthoff E.C. Transient expression of murine interferon-alpha genes in mouse and monkey cells. Gene 45 (1986) 159-165
13. Grafi G., Sela I., and Galili G. Translational regulation of human beta interferon mRNA: association of the 3′ AU-rich sequence with the poly(A) tail reduces translation efficiency in vitro. Mol. Cell. Biol. 13 (1993) 3487-3493
14. Mosca J.D., and Pitha P.M. Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis. Mol. Cell. Biol. 6 (1986) 2279-2283
15. Whittemore L.A., and Maniatis T. Postinduction turnoff of beta-interferon gene expression. Mol. Cell. Biol. 10 (1990) 1329-1337
16. Paste M., Huez G., and Kruys V. Deadenylation of interferon-beta mRNA is mediated by both the AU-rich element in the 3′-UTR region and an instability sequence in the coding region. Eur. J. Biochem. 270 (2003) 1590-1597
17. Bakheet T., Frevel M., Williams B.R., Greer W., and Khabar K.S. ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res. 29 (2001) 246-254
18. Bakheet T., Williams B.R., and Khabar K.S. ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res. 34 (2006) D111-D114
19. Chen C.Y., and Shyu A.B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20 (1995) 465-470
20. Barreau C., Paillard L., and Osborne H.B. AU-rich elements and associated factors: are there unifying principles?. Nucleic Acids Res. 33 (2005) 7138-7150
21. Khabar K.S. The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. J. Interferon Cytokine Res. 25 (2005) 1-10
22. Fan J., Heller N.M., Gorospe M., Atasoy U., and Stellato C. The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy. Eur. Respir. J. 26 (2005) 933-947
23. Raj N.B., and Pitha P.M. 65-kDa Protein binds to destabilizing sequences in the IFN-beta mRNA coding and 3′ UTR. FASEB J. 7 (1993) 702-710
24. Mosca J.D., Pitha P.M., and Hayward G.S. Herpes simplex virus infection selectively stimulates accumulation of beta interferon reporter gene mRNA by a posttranscriptional mechanism. J. Virol. 66 (1992) 3811-3822
25. Brown C.R., Nakamura M.S., Mosca J.D., Hayward G.S., Straus S.E., and Perera L.P. Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3′ ends of labile mRNA. J. Virol. 69 (1995) 7187-7195
26. Peppel K., Vinci J.M., and Baglioni C. The AU-rich sequences in the 3′ UTR region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J. Exp. Med. 173 (1991) 349-355
27. Wheelock E.F., and Sibley W.A. Circulating virus, interferon and antibody after vaccination with the 17-D strain of yellow-fever virus. N. Engl. J. Med. 273 (1965) 194-198
28. Chan S.H., Kobayashi M., Santoli D., Perussia B., and Trinchieri G. Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J. Immunol. 148 (1992) 92-98
29. Gollob J.A., Schnipper C.P., Murphy E.A., Ritz J., and Frank D.A. The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation. J. Immunol. 162 (1999) 4472-4481
30. Hodge D.L., Martinez A., Julias J.G., Taylor L.S., and Young H.A. Regulation of nuclear gamma interferon gene expression by interleukin 12 (IL-12) and IL-2 represents a novel form of posttranscriptional control. Mol. Cell. Biol. 22 (2002) 1742-1753
31. Nagy E., Buhlmann J.E., Henics T., Waugh M., and Rigby W.F. Selective modulation of IFN-gamma mRNA stability by IL-12/NKSF. Cell. Immunol. 159 (1994) 140-151
32. Matikainen S., Paananen A., Miettinen M., Kurimoto M., Timonen T., Julkunen I., and Sareneva T. IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12. Eur. J. Immunol. 31 (2001) 2236-2245
33. Musgrave B.L., Watson C.L., Haeryfar S.M., Barnes C.A., and Hoskin D.W. CD2-CD48 interactions promote interleukin-2 and interferon-gamma synthesis by stabilizing cytokine mRNA. Cell. Immunol. 229 (2004) 1-12
34. Pioli C., Pucci S., Barile S., Frasca D., and Doria G. Role of mRNA stability in the different patterns of cytokine production by CD4+ cells from young and old mice. Immunology 94 (1998) 380-387
35. Mestas J., Crampton S.P., Hori T., and Hughes C.C. Endothelial cell co-stimulation through OX40 augments and prolongs T cell cytokine synthesis by stabilization of cytokine mRNA. Int. Immunol. 17 (2005) 737-747
36. Curiel R.E., Garcia C.S., Farooq L., Aguero M.F., and Espinoza-Delgado I. Bryostatin-1 and IL-2 synergize to induce IFN-gamma expression in human peripheral blood T cells: implications for cancer immunotherapy. J. Immunol. 167 (2001) 4828-4837
37. Wang J.G., Collinge M., Ramgolam V., Ayalon O., Fan X.C., Pardi R., and Bender J.R. LFA-1-dependent HuR nuclear export and cytokine mRNA stabilization in T cell activation. J. Immunol. 176 (2006) 2105-2113
38. Mavropoulos A., Sully G., Cope A.P., and Clark A.R. Stabilization of IFN-gamma mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells. Blood 105 (2005) 282-288
39. Mattick J.S., and Makunin I.V. Non-coding RNA. Hum. Mol. Genet. 15 Spec No 1 (2006) R17-R29
40. Massirer K.B., and Pasquinelli A.E. The evolving role of microRNAs in animal gene expression. Bioessays 28 (2006) 449-452
41. Muljo S.A., Ansel K.M., Kanellopoulou C., Livingston D.M., Rao A., and Rajewsky K. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 202 (2005) 261-269
42. Ben-Asouli Y., Banai Y., Pel-Or Y., Shir A., and Kaempfer R. Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell 108 (2002) 221-232
43. Kaempfer R. RNA sensors: novel regulators of gene expression. EMBO Rep. 4 (2003) 1043-1047
44. Kaempfer R. Interferon-gamma mRNA attenuates its own translation by activating PKR: a molecular basis for the therapeutic effect of interferon-beta in multiple sclerosis. Cell Res. 16 (2006) 148-153
45. de Veer M.J., Holko M., Frevel M., Walker E., Der S., Paranjape J.M., Silverman R.H., and Williams B.R. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69 (2001) 912-920
46. Khabar K.S., Al-Haj L., Al-Zoghaibi F., Marie M., Dhalla M., Polyak S.J., and Williams B.R. Expressed gene clusters associated with cellular sensitivity and resistance towards anti-viral and anti-proliferative actions of interferon. J. Mol. Biol. 342 (2004) 833-846
47. Kuchtey J., Chefalo P.J., Gray R.C., Ramachandra L., and Harding C.V. Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type I IFN and stabilization of class I MHC mRNA. J. Immunol. 175 (2005) 2244-2251
48. Knight Jr. E., Anton E.D., Fahey D., Friedland B.K., and Jonak G.J. Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level. Proc. Natl Acad. Sci. U.S.A. 82 (1985) 1151-1154
49. Meurs E., and Hovanessian A.G. Alpha-interferon inhibits the expression of heavy chain mu messenger RNA in Daudi cells. EMBO J. 7 (1988) 1689-1696
50. Levine R.A., Seshadri T., Hann S.R., and Campisi J. Posttranscriptional changes in growth factor-inducible gene regulation caused by antiproliferative interferons. Cell Regul. 1 (1990) 215-226
51. Chatterjee D., and Savarese T.M. Posttranscriptional regulation of c-myc proto-oncogene expression and growth inhibition by recombinant human interferon-beta ser17 in a human colon carcinoma cell line. Cancer Chemother. Pharmacol. 30 (1992) 12-20
52. Ramana C.V., Grammatikakis N., Chernov M., Nguyen H., Goh K.C., Williams B.R., and Stark G.R. Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. EMBO J. 19 (2000) 263-272
53. Hamburger A.W., and Pinnamaneni G. Interferon induced increases in c-myc expression in a human breast carcinoma cell line. Anticancer Res 11 (1991) 1891-1894
54. Abu-Khabar K.S., Armstrong J.A., and Ho M. Type I interferons (IFN-alpha and -beta) suppress cytotoxin (tumor necrosis factor-alpha and lymphotoxin) production by mitogen-stimulated human peripheral blood mononuclear cell. J Leukoc Biol 52 (1992) 165-172
55. Jungo F., Dayer J.M., Modoux C., Hyka N., and Burger D. IFN-beta inhibits the ability of T lymphocytes to induce TNF-alpha and IL-1beta production in monocytes upon direct cell-cell contact. Cytokine 14 (2001) 272-282
56. Sauer I., Schaljo B., Vogl C., Gattermeier I., Kolbe T., Muller M., Blackshear P.J., and Kovarik P. Interferons limit inflammatory responses by induction of tristetraprolin. Blood 107 (2006) 4790-4797
57. Carballo E., Lai W.S., and Blackshear P.J. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95 (2000) 1891-1899
58. Carrick D.M., Lai W.S., and Blackshear P.J. The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis. Arthritis Res. Ther. 6 (2004) 248-264
59. Hitti E., Iakovleva T., Brook M., Deppenmeier S., Gruber A.D., Radzioch D., Clark A.R., Blackshear P.J., Kotlyarov A., and Gaestel M. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol. Cell. Biol. 26 (2006) 2399-2407
60. Carballo E., Cao H., Lai W.S., Kennington E.A., Campbell D., and Blackshear P.J. Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway. J. Biol. Chem. 276 (2001) 42580-42587
61. Khabar K.S., Al-Zoghaibi F., Al-Ahdal M.N., Murayama T., Dhalla M., Mukaida N., Taha M., Al-Sedairy S.T., Siddiqui Y., Kessie G., and Matsushima K. The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha. J. Exp. Med. 186 (1997) 1077-1085
62. Polyak S.J., Khabar K.S., Paschal D.M., Ezelle H.J., Duverlie G., Barber G.N., Levy D.E., Mukaida N., and Gretch D.R. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J. Virol. 75 (2001) 6095-6106
63. Bisbal C., Silhol M., Laubenthal H., Kaluza T., Carnac G., Milligan L., Le Roy F., and Salehzada T. The 2′-5′ oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation. Mol. Cell. Biol. 20 (2000) 4959-4969
64. Khabar K.S., Siddiqui Y.M., al-Zoghaibi F., al-Haj L., Dhalla M., Zhou A., Dong B., Whitmore M., Paranjape J., Al-Ahdal M.N., Al-Mohanna F., Williams B.R., and Silverman R.H. RNase L mediates transient control of the interferon response through modulation of the double-stranded RNA-dependent protein kinase PKR. J. Biol. Chem. 278 (2003) 20124-20132
65. Chandrasekaran K., Mehrabian Z., Li X.L., and Hassel B. RNase-L regulates the stability of mitochondrial DNA-encoded mRNAs in mouse embryo fibroblasts. Biochem. Biophys. Res. Commun. 325 (2004) 18-23
66. Le Roy F., Bisbal C., Silhol M., Martinand C., Lebleu B., and Salehzada T. The 2-5A/RNase L/RNase L inhibitor (RLI) [correction of (RNI)] pathway regulates mitochondrial mRNAs stability in interferon alpha-treated H9 cells. J. Biol. Chem. 276 (2001) 48473-48482
67. Li X.L., Blackford J.A., Judge C.S., Liu M., Xiao W., Kalvakolanu D.V., and Hassel B.A. RNase-L-dependent destabilization of interferon-induced mRNAs. A role for the 2-5A system in attenuation of the interferon response. J. Biol. Chem. 275 (2000) 8880-8888
68. Le Roy F., Salehzada T., Bisbal C., Dougherty J.P., and Peltz S.W. A newly discovered function for RNase L in regulating translation termination. Nat. Struct. Mol. Biol. 12 (2005) 505-512
69. Meurs E.F., Watanabe Y., Kadereit S., Barber G.N., Katze M.G., Chong K., Williams B.R., and Hovanessian A.G. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J. Virol. 66 (1992) 5804-5814
70. Balachandran S., Roberts P.C., Brown L.E., Truong H., Pattnaik A.K., Archer D.R., and Barber G.N. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13 (2000) 129-141
71. Caraglia M., Vitale G., Marra M., Del Prete S., Lentini A., Budillon A., Beninati S., and Abbruzzese A. Translational and post-translational modifications of proteins as a new mechanism of action of alpha-interferon: review article. Amino Acids 26 (2004) 409-417
72. Chawla-Sarkar M., Lindner D.J., Liu Y.F., Williams B.R., Sen G.C., Silverman R.H., and Borden E.C. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8 (2003) 237-249
73. Anderson P., and Kedersha N. Visibly stressed: the role of eIF2, TIA-1, and stress granules in protein translation. Cell Stress Chaperones 7 (2002) 213-221
74. Zhao M., Tang D., Lechpammer S., Hoffman A., Asea A., Stevenson M.A., and Calderwood S.K. Double-stranded RNA-dependent protein kinase (pkr) is essential for thermotolerance, accumulation of HSP70, and stabilization of ARE-containing HSP70 mRNA during stress. J. Biol. Chem. 277 (2002) 44539-44547
75. Xu Z., and Williams B.R. Genomic features of human PKR: alternative splicing and a polymorphic CGG repeat in the 5′-UTR region. J. Interferon Cytokine Res. 18 (1998) 609-616
76. Li S., and Koromilas A.E. Dominant negative function by an alternatively spliced form of the interferon-inducible protein kinase PKR. J. Biol. Chem. 276 (2001) 13881-13890
77. Karpova A.Y., Ronco L.V., and Howley P.M. Functional characterization of interferon regulatory factor 3a (IRF-3a), an alternative splice isoform of IRF-3. Mol. Cell. Biol. 21 (2001) 4169-4176
78. Giorelli M., Livrea P., Defazio G., Ricchiuti F., Pagano E., and Trojano M. IFN-beta1a modulates the expression of CTLA-4 and CD28 splice variants in human mononuclear cells: induction of soluble isoforms. J. Interferon Cytokine Res. 21 (2001) 809-812
79. Samuel C.E. RNA editing minireview series. J. Biol. Chem. 278 (2003) 1389-1390
80. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14 (2001) 778-809 table of contents
81. Toth A.M., Zhang P., Das S., George C.X., and Samuel C.E. Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. Prog. Nucleic Acid Res. Mol. Biol. 81 (2006) 369-434
82. Caraglia M., Marra M., Giuberti G., D'Alessandro A.M., Baldi A., Tassone P., Venuta S., Tagliaferri P., and Abbruzzese A. The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells. J. Biochem. (Tokyo) 133 (2003) 757-765
83. Caraglia M., Budillon A., Vitale G., Lupoli G., Tagliaferri P., and Abbruzzese A. Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation. Eur. J. Biochem. 267 (2000) 3919-3936
84. Liu M., Li X.L., and Hassel B.A. Proteasomes modulate conjugation to the ubiquitin-like protein, ISG15. J. Biol. Chem. 278 (2003) 1594-1602
85. Lu G., Reinert J.T., Pitha-Rowe I., Okumura A., Kellum M., Knobeloch K.P., Hassel B., and Pitha P.M. ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. Cell. Mol. Biol. (Noisy-le-grand) 52 (2006) 29-41
86. Raghavan A., Dhalla M., Bakheet T., Ogilvie R.L., Vlasova I.A., Khabar K.S., Williams B.R., and Bohjanen P.R. Patterns of coordinate down-regulation of ARE-containing transcripts following immune cell activation. Genomics 84 (2004) 1002-1013